Acetylcholine receptor extracellular domain determines sensitivity to nicotine-induced inactivation

European Journal of Pharmacology

Volumn 393, Issue 1-3, 2000, Pages 11-21

  Kuryatov, Alexander ^a   Olale, Felix A ^a   Choi, Catherine ^a   Lindstrom, Jon ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Nicotine; Nicotinic acetylcholine receptor

Indexed keywords

ACETYLCHOLINE; CHIMERIC PROTEIN; CHOLINERGIC RECEPTOR; NICOTINE; RECEPTOR SUBTYPE; RECEPTOR SUBUNIT;

ANIMAL CELL; BINDING SITE; CELL SURFACE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG SENSITIVITY; ELECTROPHYSIOLOGY; GENE CONSTRUCT; HUMAN; IN VITRO STUDY; LONG TERM EXPOSURE; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; XENOPUS LAEVIS;

ANIMALS; CHOLINERGIC AGONISTS; CHOLINERGIC ANTAGONISTS; HUMANS; MEMBRANE PROTEINS; NICOTINE; NICOTINIC AGONISTS; OOCYTES; PHOSPHORYLATION; PROTEIN CONFORMATION; RECEPTORS, CHOLINERGIC; RECOMBINANT FUSION PROTEINS; XENOPUS LAEVIS;

EID: 0034732243     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00027-3     Document Type: Article

References (42)

1. Anand R., Lindstrom J. Nucleotide sequence of the human nicotinic acetylcholine receptor β2 subunit gene. Nucleic Acids Res. 18:1990;4272.
2. Anand R., Peng X., Ballesta J., Lindstrom J. Pharmacological characterization of α-bungarotoxin-sensitive acetylcholine receptors immunoisolated from chick retina: contrasting properties of α7 and α8 subunit-containing subtypes. Mol. Pharmacol. 44:1993;1046-1050.
3. Bannon A., Decker M., Holladay M., Curzon P., Donnelly-Roberts D., Puttfarcken P., Bitner R., Diaz A., Dickenson A., Porsolt R., Williams M., Arneric S. Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors. Science. 279:1998;77-81.
4. Benowitz N., Porchet H., Jacob P. Pharmacokinetics, metabolism and pharmacodynamics of nicotine. Wonnacott S., Russell M., Stolerman I. Nicotine Psychopharmacology. 1990;112-157 Oxford Science Publications, Oxford, England.
5. Bertrand D., Changeux J.P. Nicotinic receptor: an allosteric protein specialized for intercellular communication. Semin. Neurosci. 7:1995;75-80.
6. Collins A., Marks M. Are nicotinic receptors activated or inhibited following chronic nicotine treatment? Drug Dev. Res. 38:1996;231-242.
7. Corringer P.J., Bertrand S., Bohler S., Edelstein S., Changeux J.P. Critical elements determining diversity in agonist binding and desensitization of neuronal nicotinic acetylcholine receptors. J. Neurosci. 18:1998;648-657.
8. Dani J., Heinemann S. Molecular and cellular aspects of nicotine abuse. Neuron. 16:1996;905-908.
9. Eilers H., Schaeffer E., Bickler P., Forsayeth J. Functional deactivation of the major neuronal nicotinic receptor caused by nicotine and a protein kinase C-dependent mechanism. Mol. Pharmacol. 52:1997;1105-1112.
10. Fenster C., Rains M., Noerager B., Quick M., Lester R. Influence of subunit composition on desensitization of neuronal acetylcholine receptors at low concentrations of nicotine. J. Neurosci. 17:1997;5747-5759.
11. Fenster C., Beckman M., Parker J., Sheffield E., Whitworth T., Quick M., Lester R. Regulation of α4β2 nicotinic receptor desensitization by calcium and protein kinase C. Mol. Pharmacol. 55:1999;432-443.
12. Flores C., Davila-Garcia M., Ulrich Y., Kellar K.J. Differential regulation of neuronal nicotinic receptor binding sites following chronic nicotine administration. J. Neurochem. 69:1997;2216-2219.
13. Gerzanich V., Peng X., Wang F., Wells G., Anand R., Fletcher S., Lindstrom J. Comparative pharmacology of epibatidine-a potent agonist for neuronal nicotinic acetylcholine receptors. Mol. Pharmacol. 48:1995;774-782.
14. Goldner F., Patrick J. Immunohisotochemical localization of the nicotinic acetylcholine receptor subunit α6 to dopaminergic neurons in the substantia nigra and the ventral tegmental area. Mol. Neurosci. 8:1997;2739-2742.
15. Gopalakrishnan M., Monteggia L., Anderson D., Molinari E., Piattoni-Kaplan M., Donnelly-Roberts D., Arneric S., Sullivan J. Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine α4β2 receptor. J. Pharmacol. Exp. Ther. 276:1996;289-297.
16. Heinemann S., Boulter J., Connolly J., Deneris E., Duvoisin R., Hartley M., Hermans-Borgmeyer I., Hollmann M., O'Shea-Greenfield A., Papke R., Rogers S., Patrick J. The nicotinic receptor genes. Clin. Neuropharmacol. 14:1991;S45-S61.
17. Holladay M., Dart M., Lynch J. Neuronal nicotinic acetylcholine receptors as targets for drug discovery. J. Med. Chem. 40:1997;4169-4194.
18. Hsu Y.N., Amin J., Weiss D., Wecker L. Sustained nicotine exposure differentially affects α3β2 and α4β2 neuronal nicotinic receptors expressed in Xenopus oocytes. J. Neurochem. 66:1996;667-675.
19. Hsu Y.N., Edwards S., Wecker L. Nicotine enhances the cyclic AMP-dependent protein kinase-mediated phosphorylation of α4 subunits of neuronal nicotinic receptors. J. Neurochem. 69:1997;2427-2431.
20. Karlin A. Structure of nicotinic acetylcholine receptors. Curr. Opin. Neurobiol. 3:1993;299-309.
21. Karlin A., Akabas M. Toward a structural basis for the function of nicotinic acetylcholine receptors and their cousins. Neuron. 15:1995;1231-1244.
22. Ke L., Cynthia M., Eisenhour C., Bencherif M., Lukas R. Effects of chronic nicotine treatment on expression of diverse nicotinic acetylcholine receptor subtypes: I. Dose and time-dependent effects of nicotine treatment. J. Pharmacol. Exp. Ther. 286:1998;825-840.
23. 2+ permeability, conductance and gating of human α4β2 nicotinic acetylcholine receptors. J. Neurosci. 17:1997;9035-9047.
24. Le Novere N., Changeux J.P. Molecular evolution of the nicotinic acetylcholine receptor: an example of a multi-gene family in excitable cells. J. Mol. Evol. 40:1995;155-172.
25. Le Novere N., Zoli M., Changeux J.P. Neuronal nicotinic receptor α6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain. Eur. J. Neurosci. 8:1996;2428-2439.
26. Lindstrom J. Neuronal nicotinic acetylcholine receptors. Narahashi T. Ion Channels. 4:1996;377-450 Plenum, New York.
27. Lindstrom, J., The structures of neuronal nicotinic receptors, in: Clementi, F., Gotti, C., Fornasari, D., (Eds.), Neuronal Nicotinic Receptors, Springer, New York, in press.
28. Miles K., Huganir R. Regulation of acetylcholine receptors by protein phosphorylation. Mol. Neurobiol. 2:1988;91-124.
29. Olale F., Gerzanich V., Kuryatov A., Wang F., Lindstrom J. Chronic nicotine exposure differentially affects the function of human α3, α4, and α7 neuronal nicotinic receptor subtypes. J. Pharmacol. Exp. Ther. 283:1997;675-683.
30. Papke R. The kinetic properties of neuronal nicotinic receptors: genetic basis of functional diversity. Prog. Neurobiol. 41:1993;509-531.
31. Peng X., Gerzanich V., Anand R., Whiting P., Lindstrom J. Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover. Mol. Pharmacol. 46:1994;523-530.
32. Peng X., Gerzanich V., Anand R., Wang F., Lindstrom J. Chronic nicotine treatment up-regulates α3 AChRs and α7 AChRs expressed by the human neuroblastoma cell line SH-SY5Y. Mol. Pharmacol. 46:1997;776-784.
33. Perry D., Davila-Garcia M., Stockmeirer C., Kellar K. Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies. J. Pharmacol. Exp. Ther. 289:1999;1545-1552.
34. Picciotto M., Zoli M., Rimondini R., Lena C., Marubio L., Pich E., Fuxe K., Changeux J.P. Acetylcholine receptors containing the β2 subunit are involved in reinforcing properties of nicotine. Nature. 391:1998;173-177.
35. Rowell P., Duggan D. Long-lasting inactivation of nicotinic receptor function in vitro by treatment with high concentrations of nicotine. Neuropharmacology. 37:1998;103-111.
36. Ullian E., McIntosh J., Sargent P. Rapid synaptic transmission in the avian ciliary ganglion is mediated by two distinct classes of nicotinic receptors. J. Neurosci. 17:1997;7210-7219.
37. Wang F., Gerzanich V., Wells G., Anand R., Peng X., Keyser K., Lindstrom J. Assembly of the human neuronal nicotinic receptor α3 subunit with β2, β4, and α5 subunits. J. Biol. Chem. 271:1996;1656-1665.
38. Wang F., Nelson M., Kuryatov A., Olale F., Cooper J., Keyser K., Lindstrom J. Chronic nicotine treatment upregulates α3β2, but not α3β4 AChRs stably transfected in human embryonic kidney cells. J. Biol. Chem. 273:1998;28721-28732.
39. Whiting P.J., Linstrom J.M. Characterization of bovine and human neuronal nicotinic acetylcholine receptors using monoclonal antibodies. J. Neurosci. 8:1988;3395-3404.
40. Wilson G., Karlin A. The location of the gate in the acetylcholine receptor channel. Neuron. 20:1998;1269-1281.
41. Wonnacott S. The paradox of nicotinic acetylcholine receptor upregulation by nicotine. Trends Pharmacol. Sci. 11:1990;216-219.
42. Zhang Z.W., Coggan J., Berg D. Synaptic currents generated by neuronal acetylcholine receptors sensitive to α-bungarotoxin. Neuron. 7:1996;1231-1240.